Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2437356
Max Phase: Preclinical
Molecular Formula: C27H24ClF3N2O5
Molecular Weight: 548.95
Molecule Type: Small molecule
Associated Items:
ID: ALA2437356
Max Phase: Preclinical
Molecular Formula: C27H24ClF3N2O5
Molecular Weight: 548.95
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)Oc1cc(Cl)ccc1C(=O)Nc1ccc(C(F)(F)F)cc1
Standard InChI: InChI=1S/C27H24ClF3N2O5/c1-16(2)23(33-26(36)37-15-17-6-4-3-5-7-17)25(35)38-22-14-19(28)10-13-21(22)24(34)32-20-11-8-18(9-12-20)27(29,30)31/h3-14,16,23H,15H2,1-2H3,(H,32,34)(H,33,36)/t23-/m0/s1
Standard InChI Key: LNUCMBAPWPGEHO-QHCPKHFHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 548.95 | Molecular Weight (Monoisotopic): 548.1326 | AlogP: 6.47 | #Rotatable Bonds: 8 |
Polar Surface Area: 93.73 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.71 | CX Basic pKa: | CX LogP: 6.85 | CX LogD: 6.85 |
Aromatic Rings: 3 | Heavy Atoms: 38 | QED Weighted: 0.25 | Np Likeness Score: -1.25 |
1. Pauk K, Zadražilová I, Imramovský A, Vinšová J, Pokorná M, Masaříková M, Cížek A, Jampílek J.. (2013) New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species., 21 (21): [PMID:24045008] [10.1016/j.bmc.2013.08.029] |
Source(1):